SUMMARY Using an otoadmittance meter the function of the middle ear was compared in 38 patients with rheumatoid arthritis (RA) and 30 matched controls with non-articular rheumatism. Patients with pre-existing ear disease were excluded from the study. No subjects in either group showed hearing loss on pure tone audiometry, but otoadmittance abnormalities were recorded in 16 of the RA (42%) and in 2 of the control groups (7 %). The pattern of abnormality was similar in each case and indicated an increased laxity of the conducting system. The reason for this unexpected finding is unknown. There were no significant differences between the RA patients with normal or abnormal recordings as regards clinical or laboratory features or treatment.
The pathophysiology of the middle ear in RA is unclear. Both transient (Copeman, 1963) and permanent conductive deafness (Ransome, 1964) have been described in patients with RA. Other studies have suggested that sensorineural deafness, unrelated to drug therapy, may be more common in RA than in health (Goodwill et al., 1972; Heyworth and Liyanage, 1972 (Fig. 1, tracing C) .
The otoadmittance meter employs a high frequency probe tone stimulus (660 Hz) which is close to but below the normal resonating frequency of the middle ear. In health it is unusual for the resonating frequency to be reached and a notched tracing is not produced on the tympanogram (Fig. IA) . The resonating frequency is reduced by loosening pathologies such as hypermobility of the tympanic membrane due to healed perforations, or disruption of the ossicular chain, and increased by stiffening conditions such as otosclerosis (Liden et al. 1970) . Thus pathologies which reduce the resonating frequency to below 660 Hz will produce a notch on the 660 Hz tympanogram (Fig. IB) .
We report our observations on the tympanograms of patients with RA assessed by the otoadmittance meter. Rheumatism Association criteria (Ropes et al., 1959) and a control group of 30 patients with non-articular rheumatism of similar age and sex distribution to the RA group were studied. The 68 patients had previously fulfilled the following criteria for inclusion in the survey: (1) no history of ear disease, (2) (Table 1) .
Discussion
The reason for the striking disparity between the RA and control groups is uncertain. The incidence of abnormal tympanograms in the controls corresponds with the findings of Liden et al. (1974) and may be the result of small, healed perforations of the tympanic membrane which cannot be detected on routine clinical examination. The presence of a response in the RA patients indicating a disturbance which increases the laxity of the conducting system and thus reduces the resonant frequency point is of interest. Rheumatoid involvement of the interossicular joints might be expected to produce an increase in the stiffness component of otoadmittance and thus increase the resonant point of the ear.
However, firm histological evidence of RA involvement of the interossicular joints is lacking (Gardner, 1972; Goodwill et al., 1972) and ankylosis of these joints may be unassociated with any clinical or audiometric disturbance (Etholm and Belal, 1974) . Increased collagenolysis which may occur in RA (Etherington, 1977) could contribute towards the abnormal laxity of the conducting system. Ototoxicity has to be considered in any study of the ear in RA. The ototoxic antirheumatic drugs are generally known to act on the inner ear. Salicylates, indomethacin, ibuprofen, phenylbutazone, and antimalarials have all been associated with sensorineural deafness (Ajodhia and Dix, 1976) No sensorineural abnormalities attributable to drugs were detected in any of our patients. There were also no differences between the small numbers of patients receiving systemic steroids or D-penicillamine (Table  1) both of which could theoretically increase the laxity of the conducting system by an effect on collagen metabolism.
The conducting system in RA is undoubtedly abnormal when assessed by otoadmittance. We have also noted similar tympanograms in 3 patients with ankylosing spondylitis without peripheral arthritis. Otoadmittance is an extremely sensitive technique which can reveal minimal pathophysiological changes in the conducting system. None of our patients had conductive hearing loss. Thus, we cannot comment on the deafness which others have attributed to rheumatoid disease. Our own and previous studies (Copeman, 1963; Ransome, 1964; Goodwill et al., 1972; Heyworth and Liyanage 1972) suggest that clinically significant conductive deafness is a rare phenomenon in RA.
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